These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28697465)

  • 1. Combined photodynamic and antibiotic therapy for skin disorder via lipase-sensitive liposomes with enhanced antimicrobial performance.
    Jeong S; Lee J; Im BN; Park H; Na K
    Biomaterials; 2017 Oct; 141():243-250. PubMed ID: 28697465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipase-Sensitive Transfersomes Based on Photosensitizer/Polymerizable Lipid Conjugate for Selective Antimicrobial Photodynamic Therapy of Acne.
    Park H; Lee J; Jeong S; Im BN; Kim MK; Yang SG; Na K
    Adv Healthc Mater; 2016 Dec; 5(24):3139-3147. PubMed ID: 27863184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target Proteins of Phloretin for Its Anti-Inflammatory and Antibacterial Activities Against
    Cheon D; Kim J; Jeon D; Shin HC; Kim Y
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular spicules associated with Propionibacterium acnes in response to erythromycin.
    Chia HY; Tey HL; Lee JS
    J Dermatol; 2011 Apr; 38(4):409-11. PubMed ID: 21544949
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureus.
    Ostorhazi E; Voros E; Nemes-Nikodem E; Pinter D; Sillo P; Mayer B; Wade JD; Otvos L
    Int J Antimicrob Agents; 2013 Dec; 42(6):537-43. PubMed ID: 24074727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propionibacterium: resistance of acne to antibiotics.
    Oakley A; Rademaker M; Duffill M; Leng R; Shewan J
    N Z Med J; 1995 Feb; 108(993):43-4. PubMed ID: 7891939
    [No Abstract]   [Full Text] [Related]  

  • 8. Follicular spicules associated with Propionibacterium acnes with response to erythromycin: Lack of evidence for the species?
    Dekio I
    J Dermatol; 2012 Jun; 39(6):585; author reply 586. PubMed ID: 22224953
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.
    Ryu S; Park Y; Kim B; Cho SM; Lee J; Lee HH; Gurley C; Song K; Johnson A; Armstrong CA; Song PI
    Br J Dermatol; 2014 Dec; 171(6):1358-67. PubMed ID: 25313444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.
    Pornpattananangkul D; Fu V; Thamphiwatana S; Zhang L; Chen M; Vecchio J; Gao W; Huang CM; Zhang L
    Adv Healthc Mater; 2013 Oct; 2(10):1322-8. PubMed ID: 23495239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].
    Komagata Y; Komiyama K; Nomura S
    Jpn J Antibiot; 1998 Feb; 51(2):130-6. PubMed ID: 9575439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propionibacterium acnes lipase in seborrheic dermatitis and other skin diseases and Unsei-in.
    Higaki S; Morohashi M
    Drugs Exp Clin Res; 2003; 29(4):157-9. PubMed ID: 15018307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propionibacterium acnes: infection beyond the skin.
    Perry A; Lambert P
    Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1149-56. PubMed ID: 22114965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.